MedPath

Choline salicylate

Generic Name
Choline salicylate
Drug Type
Small Molecule
Chemical Formula
C12H19NO4
CAS Number
2016-36-6
Unique Ingredient Identifier
KD510K1IQW

Overview

Choline salicylate is an anti-inflammatory pain reliever agent that is related to aspirin. It is used to decrease swelling and to treat mild-moderate pain. It is used to treat arthritis in both children and adults. This medicine can also be used for fever . Choline Salicylate is the choline salt of salicylic acid, used as an analgesic, antipyretic and antirheumatic. It relieves mild to moderate pain and reduce fever and inflammation or swelling. Choline salicylate is effective in the treatment of gout, rheumatic fever, rheumatoid arthritis and muscle injuries . This drug is also a main ingredient in teething gels to relieve pains associated with tooth growth in the infant population . The UK government has regulated its use, due to toxicity in those under 16 years of age. Topical oral salicylate gels are no longer indicated for people younger than 16 years for pain associated with infant teething, orthodontic devices, cold sores, or mouth ulcers .

Indication

The oral gel is indicated for the relief of pain and discomfort of common mouth ulcers, cold sores, denture sore spots, infant teething and mouth ulcers, and sore spots due to orthodontic devices in children .

Associated Conditions

  • Back pain
  • Cold Sore
  • Cough
  • Epiphora
  • Fever
  • Headache
  • Infection
  • Inflammation of Mouth
  • Myalgia
  • Nasal Congestion
  • Pain
  • Rhinorrhoea
  • Sneezing
  • Sore Throat
  • Teething pain
  • Wound of the Oral Cavity
  • Cold or flu syndrome
  • Minor aches and pains
  • Minor pain
  • Ulceration of the mouth

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
SORAGEL ANTISEPTIC PAIN RELIEVING ORAL GEL
SIN10428P
GEL
8.7% w/w
11/16/1998
ORA-SED JEL
SIN04948P
GEL
0.09 ml/ml
7/16/1990
BONJELA GEL
SIN04303P
GEL
8.714% W/W
4/23/1990

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
FAIR-WAY GEL
N/A
N/A
N/A
1/30/1992
ORIS-GEL
N/A
N/A
N/A
9/20/1988
OROJEL ORAL GEL
N/A
N/A
N/A
10/17/1989
ORO-SEP GEL
N/A
N/A
N/A
1/30/1992
ULC-AID GEL
N/A
N/A
N/A
6/16/1999

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
TRILISATE TAB
purdue pharma
00449636
Tablet - Oral
293 MG
12/31/1979
TEEJEL GEL
purdue pharma
00026190
Gel - Topical ,  Dental
8.7 %
12/31/1965

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.